Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Trial register facet

Trial records for Pramlintide

15 records for Pramlintide, of which 3 are published trials.

Showing 0 records on this page

Records

15 documents

Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.

RecordCompoundPhaseStatusDesignRandomisedYearCertainty
PRAM-OBESITY-PH2PramlintidePhase 2ReportedRandomised, double-blind, placebo-controlled4112007Low
PRAM-OBESITY-PH2-OLEprogramme recordPramlintidePhase 2ReportedSingle-arm open-label2007Very low
PRAM-OBESITY-PH2-ELDERLYprogramme recordPramlintidePhase 2ReportedRandomised, double-blind, placebo-controlled2007Very low
PRAM-OBESITY-PH2-BIOMARKERprogramme recordPramlintidePhase 2ReportedRandomised, double-blind, placebo-controlled2007Very low
PRAM-OBESITY-PH2-ADHERENCEprogramme recordPramlintidePhase 2ReportedObservational2007Very low
PRAM-T2D-1YRPramlintidePhase 3ReportedRandomised, double-blind, placebo-controlled6562003Moderate
PRAM-T2D-1YR-HEPATIC-IMPprogramme recordPramlintidePhase 1ReportedPhase 1 ascending dose2003Very low
PRAM-T2D-1YR-DDIprogramme recordPramlintidePhase 1ReportedRandomised crossover2003Very low
PRAM-T2D-1YR-PKprogramme recordPramlintidePhase 1ReportedPhase 1 ascending dose2003Very low
PRAM-T2D-1YR-RENAL-IMPprogramme recordPramlintidePhase 1ReportedPhase 1 ascending dose2003Very low
PRAM-T1D-PIVOTALPramlintidePhase 3ReportedRandomised, double-blind, placebo-controlled4802002Moderate
PRAM-T1D-PIVOTAL-ADHERENCEprogramme recordPramlintidePhase 3ReportedObservational2002Very low
PRAM-T1D-PIVOTAL-BIOMARKERprogramme recordPramlintidePhase 3ReportedRandomised, double-blind, placebo-controlled2002Very low
PRAM-T1D-PIVOTAL-ELDERLYprogramme recordPramlintidePhase 3ReportedRandomised, double-blind, placebo-controlled2002Very low
PRAM-T1D-PIVOTAL-OLEprogramme recordPramlintidePhase 3ReportedSingle-arm open-label2002Very low
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.